>are there any "dots" that may connect ATryn to this issue?<
There are dots, but connecting them is not on GTC’s agenda in the next few years. Perhaps this is a program they could out-license to someone line OSIP
Here’s a preclinical study re using antithrombin to thwart liver metastases: #msg-9460320. (You noted that it was “interesting” in reply to the original post.) Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”